The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Rubin, David T.
Item TypeName
Concept von Willebrand Factor
Concept Tumor Necrosis Factor-alpha
Concept STAT3 Transcription Factor
Concept STAT1 Transcription Factor
Academic Article Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.
Academic Article Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease.
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
Academic Article Serum adalimumab concentration and clinical remission in patients with Crohn's disease.
Academic Article Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.
Academic Article The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
Academic Article Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
Academic Article Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
Academic Article Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
Academic Article Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States.
Academic Article Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
Academic Article Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
Academic Article Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
Academic Article The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Academic Article Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies.
Academic Article Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors.
Academic Article Tumor angiogenesis in primary and metastatic colorectal cancers.
Academic Article Effects of vedolizumab on health-related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial.
Academic Article ACG Clinical Guideline: Ulcerative Colitis in Adults.
Academic Article Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
Academic Article Renin-angiotensin system promotes colonic inflammation by inducing TH17 activation via JAK2/STAT pathway.
Academic Article The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?
Academic Article Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
Academic Article Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
Academic Article Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
Academic Article Emerging treatment options for extraintestinal manifestations in IBD.
Academic Article The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
Academic Article Vedolizumab and Anti-Tumour Necrosis Factor a Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
Academic Article Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.
Academic Article Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn's disease.
Academic Article Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.
Academic Article Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
Academic Article Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications.
Search Criteria
  • Fibrinogen